Literature DB >> 25470808

The physical phenotype of frailty for risk stratification of older medical inpatients.

P Forti1, F Maioli, E Zagni, T Lucassenn, L Montanari, B Maltoni, G Luca Pirazzoli, G Bianchi, M Zoli.   

Abstract

OBJECTIVES: To determine the usefulness of physical phenotype of frailty, cognitive impairment, and serum albumin for risk stratification of elderly medical impatients.
DESIGN: Prospective, observational cohort study.
SETTING: A general internal medicine unit of a university hospital in Italy. PARTICIPANTS: Inpatients with an average age of 80.8 ± 7.5 yr (N = 470). MEASUREMENTS: Frailty was defined using the Study of Osteoporotic Fractures Index, a parsimonious version of the physical phenotype (two of the following markers: weight loss, inability to rise five times from a chair, and exhaustion). Two frailty markers from non-physical dimensions were also evaluated: cognitive impairment (Mini-Cog score < 3) and low serum albumin on ward admission (< 3,5 gr/dl). Logistic regression adjusted for preadmission and admission-related confounders was used to investigate whether the physical phenotype of frailty and the two non-physical markers were associated with ward length of stay and unfavorable discharge (death plus any other ward discharge disposition different from direct return home). Areas Under the receiver operating characteristic Curve (AUCs) and Likelihood Ratios (LRs) were used for evaluation of discriminatory ability and clinical usefulness of significant predictors.
RESULTS: The physical phenotype of frailty was associated with both study outcomes (p < 0.010) but the association was mainly mediated by chair standing ability. Non-physical markers were associated only with unfavourable discharge (p < 0.001). All of these predictors, either alone or in combination, had poor discriminatory ability (AUCs < 0.70) and poor clinical usefulness (+LRs near 1) for the study outcomes.
CONCLUSIONS: The physical phenotype of frailty appears of limited clinical use for risk stratification of older medical inpatients. Combination with markers from non-physical dimensions does not improve its prognostic abilities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25470808     DOI: 10.1007/s12603-014-0493-5

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  42 in total

1.  Likelihood ratio: A powerful tool for incorporating the results of a diagnostic test into clinical decisionmaking.

Authors:  S R Hayden; M D Brown
Journal:  Ann Emerg Med       Date:  1999-05       Impact factor: 5.721

Review 2.  Hospitalization-associated disability: "She was probably able to ambulate, but I'm not sure".

Authors:  Kenneth E Covinsky; Edgar Pierluissi; C Bree Johnston
Journal:  JAMA       Date:  2011-10-26       Impact factor: 56.272

3.  Contribution of frailty markers in explaining differences among individuals in five samples of older persons.

Authors:  Nadia Sourial; Howard Bergman; Sathya Karunananthan; Christina Wolfson; Jack Guralnik; Hélène Payette; Luis Gutierrez-Robledo; Dorly J H Deeg; John D Fletcher; Maria T E Puts; Bin Zhu; François Béland
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-28       Impact factor: 6.053

4.  Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction.

Authors:  Niklas Ekerstad; Eva Swahn; Magnus Janzon; Joakim Alfredsson; Rurik Löfmark; Marcus Lindenberger; Per Carlsson
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

Review 5.  Frailty in the older surgical patient: a review.

Authors:  Judith S L Partridge; Danielle Harari; Jugdeep K Dhesi
Journal:  Age Ageing       Date:  2012-03       Impact factor: 10.668

6.  Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit.

Authors:  Hans-Christian Koennecke; W Belz; D Berfelde; M Endres; S Fitzek; F Hamilton; P Kreitsch; B-M Mackert; D G Nabavi; C H Nolte; W Pöhls; I Schmehl; B Schmitz; M von Brevern; G Walter; P U Heuschmann
Journal:  Neurology       Date:  2011-08-24       Impact factor: 9.910

7.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

8.  Looking for frailty in community-dwelling older persons: the Gérontopôle Frailty Screening Tool (GFST).

Authors:  B Vellas; L Balardy; S Gillette-Guyonnet; G Abellan Van Kan; A Ghisolfi-Marque; J Subra; S Bismuth; S Oustric; M Cesari
Journal:  J Nutr Health Aging       Date:  2013-07       Impact factor: 4.075

9.  Comparing the prognostic accuracy for all-cause mortality of frailty instruments: a multicentre 1-year follow-up in hospitalized older patients.

Authors:  Alberto Pilotto; Franco Rengo; Niccolò Marchionni; Daniele Sancarlo; Andrea Fontana; Francesco Panza; Luigi Ferrucci
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

10.  Validation and comparison of two frailty indexes: The MOBILIZE Boston Study.

Authors:  Dan K Kiely; L Adrienne Cupples; Lewis A Lipsitz
Journal:  J Am Geriatr Soc       Date:  2009-07-21       Impact factor: 5.562

View more
  3 in total

1.  Frailty Assessment in Hospitalized Older Adults Using the Electronic Health Record.

Authors:  Deborah A Lekan; Debra C Wallace; Thomas P McCoy; Jie Hu; Susan G Silva; Heather E Whitson
Journal:  Biol Res Nurs       Date:  2017-01-25       Impact factor: 2.522

2.  Machine learning for predicting readmission risk among the frail: Explainable AI for healthcare.

Authors:  Somya D Mohanty; Deborah Lekan; Thomas P McCoy; Marjorie Jenkins; Prashanti Manda
Journal:  Patterns (N Y)       Date:  2021-12-03

Review 3.  What do we know about frailty in the acute care setting? A scoping review.

Authors:  Olga Theou; Emma Squires; Kayla Mallery; Jacques S Lee; Sherri Fay; Judah Goldstein; Joshua J Armstrong; Kenneth Rockwood
Journal:  BMC Geriatr       Date:  2018-06-11       Impact factor: 3.921

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.